tirzepatide and alzheimer's prevention the Brain: A Breakthrough in Combating Diabetes-Linked Neurodegeneration Prevention of Dementia with GLP-1
Description
But when generics come out later this year, that could change
The study, led by neuroscientist Amber Alhadeff and her team, focused on semaglutide, the active ingredient in GLP-1 drugs such as Wegovy and Ozempic
137 WillenbringR
It is the mechanism behind Mounjaro, approved for type 2 diabetes, and Zepbound, approved for chronic weight management
